A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy

P Y K Van den Bergh1, Y Sznajer2, V Van Parys1

  • 1Neuromuscular Reference Centre, University Hospital St-Luc, University of Louvain, Brussels, Belgium.

Insights

Mutations in DPM3, a gene involved in O-linked glycosylation, can cause limb girdle muscular dystrophy. This study identifies a novel DPM3 mutation leading to mild, isolated muscle weakness without heart issues.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • O-linked glycosylation defects in alpha-dystroglycan are linked to various muscular dystrophies.
  • These defects range from severe congenital forms with developmental abnormalities to milder limb girdle muscular dystrophies.

Observation:

  • A 42-year-old female presented with isolated pelvic girdle muscle weakness and wasting.
  • Exome sequencing revealed a homozygous mutation (c.131T>G, p.Leu44Pro) in the DPM3 gene.

Findings:

  • The identified DPM3 mutation reduced dolichol-P-mannose (DPM) synthase activity by 50%.
  • This decrease in DPM availability impairs O-mannosylation of alpha-dystroglycan in skeletal muscle.
  • The patient exhibited a mild limb girdle muscular dystrophy phenotype without cardiomyopathy.

Implications:

  • DPM3 mutations can result in isolated limb girdle muscular dystrophy.
  • This expands the known phenotypic spectrum of DPM3-associated muscular dystrophies.
  • Understanding these genetic underpinnings is crucial for diagnosis and potential therapeutic strategies.